Literature DB >> 24470278

Rehabilitation perspectives of neuromodulation.

Mehul J Desai1, Michael J Ingraham.   

Abstract

Chronic pain is one of the most prevalent and costly health care problems in the United States today. Two conditions, failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS), in particular have been difficult to manage, resulting in increased disability and poorer quality of life measures for patients as well as increased treatments cost for payers. Given the cost of chronic pain management and overall subjectivity of analog pain scores, many payers are emphasizing the importance of functional outcomes as a means of assessing efficacy of treatment. Neuromodulation devices such as spinal cord stimulators are shown to be cost effective and able to improve functional outcomes and quality of life. Specific rehabilitation therapies also demonstrate improved functional outcomes. This article aims to discuss the role of rehabilitation in the patient with a neuromodulatory device. From the available data and our clinical experience, we recommend incorporating rehabilitation after placement of a neuromodulation device in order to optimize functional outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24470278     DOI: 10.1007/s11916-013-0393-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  30 in total

1.  Medicare and Medicaid financing of pain management.

Authors:  T S Jost
Journal:  J Pain       Date:  2000       Impact factor: 5.820

2.  Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I.

Authors:  H M Oerlemans; R A Oostendorp; T de Boo; L van der Laan; J L Severens; J A Goris
Journal:  Arch Phys Med Rehabil       Date:  2000-01       Impact factor: 3.966

Review 3.  Treatment of complex regional pain syndrome: functional restoration.

Authors:  R Norman Harden; Melanie Swan; Amie King; Brienne Costa; Jennifer Barthel
Journal:  Clin J Pain       Date:  2006-06       Impact factor: 3.442

4.  Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial.

Authors:  Richard B North; David H Kidd; Farrokh Farrokhi; Steven A Piantadosi
Journal:  Neurosurgery       Date:  2005       Impact factor: 4.654

5.  Pain and reduced mobility in complex regional pain syndrome I: outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy.

Authors:  H M Oerlemans; R A Oostendorp; T de Boo; R J Goris
Journal:  Pain       Date:  1999-10       Impact factor: 6.961

6.  Automated, patient-interactive, spinal cord stimulator adjustment: a randomized controlled trial.

Authors:  Richard B North; Sherri-Kae Calkins; David S Campbell; Jeffrey M Sieracki; Steven Piantadosi; Michael John Daly; P Bobby Dey; Giancarlo Barolat
Journal:  Neurosurgery       Date:  2003-03       Impact factor: 4.654

Review 7.  Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain.

Authors:  Robert J Gatchel; Akiko Okifuji
Journal:  J Pain       Date:  2006-11       Impact factor: 5.820

8.  Treatment of reflex sympathetic dystrophy of the hand with an active "stress loading" program.

Authors:  H K Watson; L Carlson
Journal:  J Hand Surg Am       Date:  1987-09       Impact factor: 2.230

9.  Relationship between health-related quality of life, pain, and functional disability in neuropathic pain patients with failed back surgery syndrome.

Authors:  Andrea Manca; Sam Eldabe; Eric Buchser; Krishna Kumar; Rod S Taylor
Journal:  Value Health       Date:  2009-08-20       Impact factor: 5.725

10.  Physical therapy and cognitive-behavioral treatment for complex regional pain syndromes.

Authors:  Benjamin H Lee; Lisa Scharff; Navil F Sethna; Claire F McCarthy; Jennifer Scott-Sutherland; Alice M Shea; Penny Sullivan; Petra Meier; David Zurakowski; Bruce J Masek; Charles B Berde
Journal:  J Pediatr       Date:  2002-07       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.